Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors
- PMID: 7583169
Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors
Abstract
Cytokines are bioactive molecules which mediate host responses to inflammatory stimuli. For cytokines to exert their effects, a number of molecular processes must occur. Inflammatory cells must sense the presence of a stimulus, often by detection of that stimulus via cell-surface receptors. Information detected at the cell surface must be transduced intracellularly, and the machinery of cytokine messenger RNA and protein synthesis initiated. Once secreted, cytokines must bind specific receptors on target tissues; these receptors in turn transduce signals which alter target cell phenotypes and responses. Each one of these steps is tightly regulated and may serve as a target for therapeutic manipulation. In this article, the regulation of cytokine gene expression is summarized, with particular emphasis on the regulation of tumor necrosis factor alpha and interleukin-1 biosynthesis. Attention is focused on therapeutic agents which alter cytokine production or activity, some of which are currently used in the ICU.
Similar articles
-
Endotoxin-induced cytokine gene expression and excretion in the liver.Hepatology. 1994 Feb;19(2):480-8. Hepatology. 1994. PMID: 8294104
-
Soluble cytokine receptors in disease.Isr J Med Sci. 1995 Sep;31(9):565-71. Isr J Med Sci. 1995. PMID: 7558783 Review. No abstract available.
-
A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.Cytokine. 1997 May;9(5):340-6. doi: 10.1006/cyto.1996.0174. Cytokine. 1997. PMID: 9195133
-
Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.J Rheumatol. 1999 Mar;26(3):645-53. J Rheumatol. 1999. PMID: 10090177
-
[Cytokines and antagonists in septic shock].Schweiz Med Wochenschr. 1993 Mar 20;123(11):480-91. Schweiz Med Wochenschr. 1993. PMID: 8386392 Review. French.
Cited by
-
Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity.J Mol Model. 2012 Jun;18(6):2513-25. doi: 10.1007/s00894-011-1265-3. Epub 2011 Oct 27. J Mol Model. 2012. PMID: 22038459
-
[Intensive insulin therapy in sepsis. Improvement of survival chances?].Anaesthesist. 2003 Dec;52 Suppl 1:S20-3. doi: 10.1007/s00101-003-0590-z. Anaesthesist. 2003. PMID: 14727047 Review. German. No abstract available.
-
Development of QSAR model for immunomodulatory activity of natural coumarinolignoids.Drug Des Devel Ther. 2010 Sep 7;4:173-86. doi: 10.2147/dddt.s10875. Drug Des Devel Ther. 2010. PMID: 20856844 Free PMC article.
-
Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats.Ann Surg. 2000 Mar;231(3):408-16. doi: 10.1097/00000658-200003000-00014. Ann Surg. 2000. PMID: 10714634 Free PMC article.
-
Role of nitric oxide in liver ischemia and reperfusion injury.Mol Cell Biochem. 2002 May-Jun;234-235(1-2):229-37. Mol Cell Biochem. 2002. PMID: 12162439